Reminyl 8mg. 16mg. 24mg Capsule
PDF Leaflet Revision Date: Feb 2012
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of mild to moderately severe dementia of the Alzheimer type.
Dosage (summary)
Starting dose: 8 mg/day for 4 weeks; Maintenance: 16 mg/day, may increase to 24 mg/day.
Onset of Action / Duration
Onset: 1.2 hours, Duration: 7-8 hours
Special Populations
- Moderate hepatic impairment
- Severe hepatic impairment
- Moderate renal impairment
- Severe renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- CYP2D6 inhibitors
- CYP3A4 inhibitors
- Anticholinergic medications
Contraindications
- Hypersensitivity to galantamine
- Severe hepatic impairment
- Severe renal impairment
- Urinary outflow obstruction
Common side effects
- Nausea
- Vomiting
- Dizziness
- Fatigue
- Bradycardia
Counselling Points
- Take with food
- Monitor for gastrointestinal symptoms
- Avoid abrupt discontinuation
Serious warnings
- Monitor weight loss
- Caution in bradycardia
- Risk of seizures in epilepsy
Important Disclaimer
The Reminyl 8mg. 16mg. 24mg Capsule professional information leaflet below is the property of Janssen Phamaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
